Showing results (191-200 of 197) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Journal of Medicinal Chemistry|November 1, 1985
Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agentsR Paul, J A Brockman, W A Hallett, et al.The Journal of Steroid Biochemistry and Molecular Biology|February 19, 2002
Aromatase-deficient (ArKO) mice accumulate excess adipose tissueM E Jones, A W Thorburn, K L Britt, et al.International Journal of Obesity (2005)|May 27, 2005
Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE studyS G Terra, S P McGorray, R Wu, et al.Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.Heart (British Cardiac Society)|August 12, 2009
Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) studyD S Krantz, K S Whittaker, J L Francis, et al.Biochemical Pharmacology|March 23, 1999
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)C M Discafani, M L Carroll, M B Floyd, et al.Journal of Medicinal Chemistry|September 1, 2000
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitorsA Wissner, D M Berger, D H Boschelli, et al.Pageof 20